Hubert Rose Consulting is a health strategy and evidence advisory firm helping biotech teams move from evidence complexity to decision clarity.
Proprietary E2D toolkit used to support structured evidence review. Final judgments are made by senior experts
Evidence is only sufficient if it can withstand the decision standards of the stakeholder who needs to act on it.
We name what the evidence does and doesn't resolve, plainly.
Our E2D toolkit is updated as evidence standards, stakeholder expectations, and market access requirements evolve.
We help teams assess what evidence exists, where the strategy is vulnerable, what evidence is still needed, and which actions should be prioritized to support the asset value, payer readiness, launch planning, and lifecycle decisions. Our work is grounded in a proprietary E2D Toolkit, a structured internal framework used to evaluate evidence packages against stakeholder needs, decision risks, and asset strategy requirements.
Start a conversation